首页> 美国卫生研究院文献>Annals of Thoracic and Cardiovascular Surgery >The Utility of a 3D Endoscope and Robot-Assisted System for MIDCAB
【2h】

The Utility of a 3D Endoscope and Robot-Assisted System for MIDCAB

机译:MIDCAB的3D内窥镜和机器人辅助系统的实用程序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Minimally invasive direct coronary artery bypass (MIDCAB) has been revived with new techniques and hybrid procedures for MIDCAB and percutaneous coronary intervention (PCI). We reviewed the midterm results of MIDCAB with a three-dimensional (3D) endoscope in our institution.Methods: Of the 359 patients who underwent off-pump coronary artery bypass grafting (CABG) from December 2013 to March 2017, 54 had MIDCAB with the left internal thoracic artery (LITA) to left anterior descending (LAD) artery through a small left thoracotomy with a 3D endoscope. The same intercostal space was used for the main surgical incision and the insertion site of the 3D endoscope. In all, 22 patients had hybrid coronary revascularization (HCR), combined PCI and MIDCAB.Results: There was no operative death. One patient had cerebral infarction without disability. No cases showed significant increases in CKMB. In all, 34 patients commenced ambulation on postoperative day 1. The postoperative hospital stay was 9.1 ± 5.0 days. In total, 37 patients had coronary computed tomography (CT), and their patency of LITA was 100%. In HCR, there was no mortality and major adverse cardiovascular event (MACE). Target lesion revascularization among 12 months was 1.6%.Conclusion: The midterm results of MIDCAB with 3D endoscope-assisted LITA harvesting were satisfactory. MIDCAB, including HCR, is a good alternative for selected high-risk patients.
机译:背景:采用MIDCAB和经皮冠状动脉介入治疗(PCI)的新技术和混合程序已使微创直接冠状动脉搭桥术(MIDCAB)恢复。我们采用三维(3D)内窥镜检查了MIDCAB的中期结果。方法:2013年12月至2017年3月进行的359例接受体外循环冠状动脉搭桥术(CABG)的患者中,有54例行MIDCAB左胸内动脉(LITA)到左前降支(LAD)动脉通过3D内窥镜通过小的左开胸手术。相同的肋间隙用于主要手术切口和3D内窥镜的插入部位。共有22例患者进行了混合冠状动脉血运重建(HCR),PCI和MIDCAB联合治疗。结果:无手术死亡。一名患者患有无障碍性脑梗塞。没有病例显示CKMB显着增加。总共有34例患者在术后第1天开始下床活动。术后住院时间为9.1±5.0天。共有37例患者进行了冠状动脉计算机断层扫描(CT),其LITA的通畅率为100%。在HCR中,没有死亡率和严重的不良心血管事件(MACE)。在12个月内目标病变血运重建率为1.6%。结论:MIDCAB结合3D内窥镜辅助LITA采集的中期结果令人满意。 MIDCAB,包括HCR,对于某些高危患者是一个很好的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号